Behind the report: 2025 drug reimbursement trends explained live

Price transparency is reshaping the US drug reimbursement landscape, exposing previously opaque payer and provider negotiation dynamics — like why some providers are reimbursed at 1–2× their costs and others at 10×.

Drawing on the Turquoise Health and ZS Drug Reimbursement Trends Report, this session unpacks how reimbursement varies across therapy areas, products, payers, and sites of care.

We cover:

• The gap between commercial and Medicare Advantage rates
• Drivers of reimbursement variability across therapy areas
• Regional payer/provider reimbursement dynamics
• How manufacturers can use transparency data to anticipate reimbursement challenges, strengthen payer and provider relationships, and improve patient affordability strategies